Screener Companies About
OTC:GRPS
Healthcare Drug Manufacturers - Specialty & Generic

Trans American Aquaculture, Inc

Trans American Aquaculture aims to bridge the demand for sustainable seafood through US-based aquaculture development projects.

■ Key Metrics

Revenue
$331.6K
Net Income
$-2.8M
Gross Profit
$10.0K
Operating Cash Flow
$-3.0M
Total Assets
$948.0K
Shareholders' Equity
$-3.2M
Cash & Equiv
$0

⚖ Investment Thesis

Bull Case

Investors may view GRPS as a high-risk, high-reward play on the growing global demand for sustainable protein, betting that future facility completions will unlock significant recurring revenue. The company's focus on premium salmon species in North America offers a strategic moat against lower-cost competitors, and recent investing cash flows suggest potential access to capital or asset monetization. If development milestones are met, the transition from negative operations to positive cash flow could result in substantial multiple expansion for the OTC ticker.

Bear Case

The stock presents severe financial distress indicators with total liabilities of $4.2M exceeding assets, a net profit loss of $2.8M, and zero cash on hand. Revenue generation is critically weak at only $331k while operating expenses consume nearly all income, indicating an unsustainable burn rate without consistent external financing. The lack of current assets and significant debt obligations create a high probability of dilution or delisting if the company cannot secure new project funding quickly.

◉ About Trans American Aquaculture, Inc

Trans American Aquaculture, Inc. (GRPS) is a developer of sustainable aquaculture facilities focused on producing high-value fish species such as salmon and trout in the United States and Canada. The company targets global markets seeking protein-rich, environmentally friendly seafood alternatives, leveraging land-based systems to reduce pressure on wild fisheries. Key products include farmed Atlantic salmon, rainbow trout, and other premium finfish cultivated under controlled environmental conditions.

⚙ Analysis

Management Discussion

The company reported a net loss of $2.8M in the latest period, driven by high operating expenses totaling $2.8M against minimal revenue of $331k, resulting in negative cash flow from operations of $3.0M. While investing activities generated $6.7M in cash inflows, likely from project financing or asset disposals, this was offset by a $3.7M outflow from financing, leaving the company with no ending cash and zero current assets relative to liabilities. The substantial accumulated deficit suggests the business is still in an aggressive expansion or development phase rather than a mature cash-generating stage.

Industry Overview

The global aquaculture industry is experiencing robust growth as wild fish stocks decline and consumer demand for sustainable seafood rises, with North America being a key emerging market for land-based production. However, the sector faces intense capital intensity and long development cycles, particularly in the US where regulatory hurdles are high. Trans American Aquaculture operates at the forefront of this transition but must navigate significant financial constraints before achieving commercial scale.

☰ Financial Statements

Income Statement
Balance Sheet
Cash Flow
Metric2024
Revenue$331.6K
Cost of Revenue$321.6K
Gross Profit$10.0K
Operating Expenses$2.8M
Operating Income$-2.8M
G&A$846.2K
D&A$52.3K
Depreciation$19.5K
Other OpEx$2.0M
Non-Operating Income$0
Pre-Tax Income$-2.8M
Income Tax$0
Continuing Ops$-2.8M
Discontinued Ops$0
Net Income$-2.8M
Minority Interest$0
Net to Common$-2.8M
Metric2024
Current Assets$257.3K
Cash & Equivalents$0
Inventory$230.8K
Other Current Assets$26.5K
Long-Term Assets$690.7K
Total Assets$948.0K
Current Liabilities$3.6M
Accounts Payable$530.8K
Other Current Liab$3.1M
Long-Term Liabilities$561.1K
Total Liabilities$4.2M
Shareholders' Equity$-3.2M
Retained Earnings$-5.7M
Total L&E$948.0K
Metric2024
Net Income (CFO)$-2.8M
Non-Cash Adjustments$79.7K
Working Capital Changes$-267.6K
Cash from Operations$-3.0M
Cash from Investing$6.7M
Dividends Paid$0
Cash from Financing$-3.7M
FX Effect$0
Net Change in Cash$-6.6K
Beginning Cash$6.6K
Ending Cash$0

Frequently Asked Questions

How does Trans American Aquaculture, Inc make money?

1) Commercial fish production from operational or near-operational land-based facilities targeting premium Atlantic salmon and rainbow trout; 2) Project development and construction of new aquaculture sites including permitting, site selection, and infrastructure build-out; 3) Strategic partnerships and joint ventures with international investors to fund large-scale capital projects; 4) Ancillary revenue streams from waste management integration or potential by-product processing.

What are the main risks for GRPS?

1) Significant capital expenditure requirements leading to negative operating cash flow and a substantial retained earnings deficit of $5.7M; 2) Regulatory uncertainty regarding water discharge permits and environmental compliance in the US and Canada; 3) Volatility in feed costs and energy prices which directly impact gross profit margins on a thin revenue base of only $331k; 4) OTC market liquidity constraints and lack of analyst coverage making valuation difficult and exit strategies for investors challenging.

What is GRPS's competitive advantage?

1) Proven expertise in complex land-based aquaculture engineering and regulatory permitting within North America, reducing project risk for institutional partners; 2) Focus on high-margin species like Atlantic salmon that command premium prices compared to generic farmed fish; 3) Strategic location advantages with access to cold-water regions and established supply chains for feed and distribution.

Related Companies

Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.